Caricamento...
Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease
BACKGROUND: Continuous erythropoiesis receptor activator (CERA) is a newer, longer acting ESA which might be preferred to other ESAs (epoetin or darbepoetin) based on its lower frequency of administration. Different dosing requirements and molecular characteristics of CERA compared with other ESAs m...
Salvato in:
| Pubblicato in: | Cochrane Database Syst Rev |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley & Sons, Ltd
2017
|
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6483666/ https://ncbi.nlm.nih.gov/pubmed/28782299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD009904.pub2 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|